Bendamustine

From WikiMD.org
Jump to navigation Jump to search

Bendamustine (pronounced ben-da-MUS-teen) is a chemotherapy drug used in the treatment of certain types of cancer, including chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL).

Etymology

The name "Bendamustine" is derived from the combination of two words: "benzimidazole" and "mustard". The "benzimidazole" part of the name refers to the benzimidazole ring structure found in the compound, while "mustard" refers to the alkylating mustard group, which is responsible for the drug's cytotoxic activity.

Pharmacology

Bendamustine is classified as an alkylating agent, which means it works by damaging the DNA of cancer cells, preventing them from dividing and growing. It is also considered a purine analog, as it interferes with DNA synthesis by mimicking the structure of purine bases.

Usage

Bendamustine is used in the treatment of certain types of cancer, including chronic lymphocytic leukemia and non-Hodgkin lymphoma. It may be used alone or in combination with other chemotherapy drugs.

Side Effects

Like all chemotherapy drugs, Bendamustine can cause side effects. These may include nausea, vomiting, fatigue, and hair loss. More serious side effects can include low blood counts, infection, and infertility.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski